Market Insights and Analysis: Immuno-Oncology Assay Market Overview and Projections (2023-2028)
The Global Immuno-Oncology Assay Market size is valued at around USD 5.77 billion in 2024 and is estimated to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28.
Top leading companies in the Immuno-Oncology Assay Market includes:
Agilent Technologies Inc., Aviva Systems Biology Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina Inc., Qiagen N.V, Thermo Fisher Scientific, Inc., Sartorius AG, NanoString Technologies, Inc., BioGenex, Abbott Laboratories, Inc., Asuragen Inc., Meso Scale Assay, LLC, Merck Millipore, Enzo Biochem Inc., and Others
Global Immuno-Oncology Assay Market Driver: Increasing Cancer Cases Globally to Drive Immuno-Oncology Assay Market
The substantial growth in the Global Immuno-Oncology Assay Market has been attributed to the increasing prevalence of cancer globally. The global incidence of cancer has risen significantly, with notable increases reported in countries such as the US and India, as documented by leading healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, and the Global Cancer Observatory. For instance,
In 2018, the Global Cancer Observatory recorded approximately 18.1 million cancer cases worldwide, a number that escalated to approximately 19.2 million by 2020.
This surge in cancer cases has underscored the imperative for effective management. Consequently, countries, particularly the United States and India, have implemented measures to combat cancer, leading to heightened awareness among patients. This heightened awareness has driven the need for immune-oncology assays globally, catering to the need for early-stage detection and diagnosis.
Furthermore, global cancer research and healthcare organizations predict a continued increase in cancer cases in the years ahead. This prediction is based on factors such as the proliferation of carcinogenic pollutants in the environment and the growing prevalence of genetic mutations as significant contributors to cancer development. As a result, the demand for better immune-oncology diagnostic services would amplify in the coming years as well.
“In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/immuno-oncology-assay-market.html
Report Segmentation:
The market is categorized into the following segments in the report:
By Product & Services
-Reagents and Antibodies
-Testing Kits
-Instruments
-Consumables & Accessories
-Software
- reagents and antibodies are pivotal components that play a significant role in cancer diagnosis and monitoring, owing to which, they have been dominating the Global Immuno-Oncology Assay Market over the historical years.
By Assay Type
-Checkpoint Inhibitor Assays
-Cytokine Profiling Assays
-Protein Biomarker Assays
-Genomic Sequencing and Mutational Analysis
-Immune Profiling Assays
-Tumour Biomarker Assays
-Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)
By Technology
-Polymerase Chain Reaction
-Immunoassay
-Next-generation Sequencing
-In-situ Hybridization
-Flow Cytometry
-Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.)
By Indication
-Lung Cancer
-Breast Cancer
-Colorectal Cancer
-Prostate Cancer
-Ovarian Cancer
-Others (Bladder Cancer, Melanoma, etc.)
By Application
-Clinical Assay
-Research & Development
By End User
-Hospitals
-Cancer Research Centers
-Specialty Cancer Clinics
-Clinical Laboratories
-Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.)
Explore Our Comprehensive Study Reports – https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html
Immuno-Oncology Assay Market Geographic Reach:
The Geographic Reach of the Olive Market evaluates the spread and significance of Immuno-Oncology Assay Market consumption across different regions/country, emphasizing areas with the largest market size and the most promising growth potential.
- North America: US, Canada, Mexico
- Europe: The UK, Germany, Italy, France, Spain, Rest of Europe,
- Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
- South America: Brazil, Rest of South America
- Middle East & Africa: GCC, South Africa, Rest of MEA
Note: If you require specific information not covered in the current report, we can provide it through customized option
Related Reports: –
https://www.openpr.com/news/3367332/japan-tire-market-surpasses-usd-119-32-million-in-2022-set
https://www.openpr.com/news/3366272/cloud-kitchen-market-s-resilient-growth-at-12-42-cagr
https://www.openpr.com/news/3363980/geographical-insights-competitor-landscape-and-future-scope
https://www.openpr.com/news/3361209/baby-food-market-exceeds-usd-69-76-billion-in-2022-projected
https://www.openpr.com/news/3359424/generative-ai-market-exceeds-usd-12-million-in-2022-projected
Why choose Us?
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
